We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Role of Stress in Self-Control, Coping, and Emotion Regulation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01554501
Recruitment Status : Completed
First Posted : March 15, 2012
Last Update Posted : November 30, 2016
Information provided by (Responsible Party):

March 1, 2012
March 15, 2012
November 30, 2016
November 2007
December 2015   (Final data collection date for primary outcome measure)
Stress response and lifestyle behaviors [ Time Frame: Baseline ]
Study explores differences in measures of stress as they relate to self-control, coping, emotion regulation and lifestyle and health outcomes.
Same as current
Complete list of historical versions of study NCT01554501 on ClinicalTrials.gov Archive Site
Biological stress responses [ Time Frame: Baseline ]
Same as current
Not Provided
Not Provided
The Role of Stress in Self-Control, Coping, and Emotion Regulation
The Role of Stress in Self-Control, Coping and Emotion Regulation
The purpose of this study is to examine the effects of stress on mental and physical health and behavior.
Not Provided
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Blood taken for understanding genetic factors.
Non-Probability Sample
Community sample
Not Provided
Community sample
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
December 2015
December 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • ages 18-50
  • able to read and write

Exclusion Criteria:

  • Any psychotic disorder or current psychiatric symptoms requiring specific attention, including active symptoms of psychosis or suicidal/homicidal ideation
  • Pregnant women
  • Inability to give informed consent
  • Traumatic brain injury or loss of consciousness
Sexes Eligible for Study: All
18 Years to 50 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
5PL1DA024859-05 ( U.S. NIH Grant/Contract )
Not Provided
Not Provided
Rajita Sinha, Yale University
Yale University
  • National Institutes of Health (NIH)
  • National Institute on Drug Abuse (NIDA)
Principal Investigator: Rajita Sinha, PhD Yale University
Yale University
November 2016